share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Officer Mandadi Tilak

SEC announcement ·  Apr 3 16:55
Summary by Moomoo AI
On April 1, 2024, CVS Health EVP and Chief Technology Officer, Mandadi Tilak, was granted 16,339 shares of common stock (RSU) as part of a transaction with the company. The grant, which was completed on the same day, was issued at no cost to the recipient. Following this transaction, Tilak's direct holdings in CVS Health increased to a total of 82,904 shares of common stock. This event reflects the company's ongoing incentive plans for its executive leadership.
On April 1, 2024, CVS Health EVP and Chief Technology Officer, Mandadi Tilak, was granted 16,339 shares of common stock (RSU) as part of a transaction with the company. The grant, which was completed on the same day, was issued at no cost to the recipient. Following this transaction, Tilak's direct holdings in CVS Health increased to a total of 82,904 shares of common stock. This event reflects the company's ongoing incentive plans for its executive leadership.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more